17 results

e61 Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma
Leonardo Micheletti, Mario Preti, Viviana Cintolesi, Elisabetta Corvetto, Silvana Privitera, Eleonora Palmese, Chiara Benedetto
J Gynecol Oncol. 2018;29(5):e61.  Published online 2018 April 13    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e61
         
e64 Burden of cervical neoplasia in mid-western rural Nepal: a population-based study
Niresh Thapa, Girishma Shrestha, Muna Maharjan, Deborah Lindell, Ninu Maskey, Rajiv Shah, Caiyun Ge, Hongbing Cai
J Gynecol Oncol. 2018;29(5):e64.  Published online 2018 April 18    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e64
         
e65 A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study
Zheng Feng, Hao Wen, Zhaoxia Jiang, Shuai Liu, Xingzhu Ju, Xiaojun Chen, Lingfang Xia, Junyan Xu, Rui Bi, Xiaohua Wu
J Gynecol Oncol. 2018;29(5):e65.  Published online 2018 April 23    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e65
         
e66 Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer
Giorgio Bogani, Diego Rossetti, Antonino Ditto, Fabio Martinelli, Valentina Chiappa, Lavinia Mosca, Umberto Leone Roberti Maggiore, Stefano Ferla, Domenica Lorusso, Francesco Raspagliesi
J Gynecol Oncol. 2018;29(5):e66.  Published online 2018 April 23    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e66
         
e67 Clinical associations of Trousseau's syndrome associated with cerebral infarction and ovarian cancer
Hirokuni Takano, Keiko Nakajima, Yoko Nagayoshi, Hiromi Komazaki, Jiro Suzuki, Hiroshi Tanabe, Shigeki Niimi, Seiji Isonishi, Aikou Okamoto
J Gynecol Oncol. 2018;29(5):e67.  Published online 2018 April 23    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e67
         
e68 The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer
Randa J. Jalloul, Alpa M. Nick, Mark F. Munsell, Shannon N. Westin, Pedro T. Ramirez, Michael Frumovitz, Pamela T. Soliman
J Gynecol Oncol. 2018;29(5):e68.  Published online 2018 May 4    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e68
         
e69 Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer
Koji Matsuo, Hiroko Machida, Andrea Mariani, Rachel S. Mandelbaum, Gretchen E. Glaser, Bobbie S. Gostout, Lynda D. Roman, Jason D. Wright
J Gynecol Oncol. 2018;29(5):e69.  Published online 2018 May 4    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e69
         
e70 Negative peritoneal washing cytology during interval debulking surgery predicts overall survival after neoadjuvant chemotherapy for ovarian cancer
Ayaka Iura, Morihito Takita, Aiko Kawano, Kazuaki Imai, Katsuyuki Konnai, Ryo Onose, Hisamori Kato
J Gynecol Oncol. 2018;29(5):e70.  Published online 2018 May 4    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e70
         
e72 The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients
Soyi Lim, Yun Hwan Kim, Kwang-Beom Lee, Jong-Min Lee
J Gynecol Oncol. 2018;29(5):e72.  Published online 2018 May 4    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e72
         
e76 Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: a Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study
Hung-Chun Fu, Jen-Ruei Chen, Min-Yu Chen, Keng-Fu Hsu, Wen-Fang Cheng, An-Jen Chiang, Yu-Min Ke, Yu-Chieh Chen, Yin-Yi Chang, Chia-Yen Huang, Chieh-Yi Kang, Yuan-Yee Kan, Sheng-Mou Hsiao, Ming-Shyen Yen
J Gynecol Oncol. 2018;29(5):e76.  Published online 2018 May 15    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e76
         
e77 Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131)
Shin Nishio, Satomi Aihara, Mototsugu Shimokawa, Akira Fujishita, Shuichi Taniguchi, Toru Hachisuga, Shintaro Yanazume, Hiroaki Kobayashi, Fumihiro Murakami, Fumitaka Numa, Kohei Kotera, Naofumi Okura, Naoyuki Toki, Masatoshi Yokoyama, Kimio Ushijima
J Gynecol Oncol. 2018;29(5):e77.  Published online 2018 May 15    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e77
         
e78 Using low-coverage whole genome sequencing technique to analyze the chromosomal copy number alterations in the exfoliative cells of cervical cancer
Tong Ren, Jing Suo, Shikai Liu, Shu Wang, Shan Shu, Yang Xiang, Jing-He Lang
J Gynecol Oncol. 2018;29(5):e78.  Published online 2018 June 29    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e78
         
e79 Teenage pregnancy complicated by primary invasive ovarian cancer: association for oncologic outcome
Erin A. Blake, Madushka Y. De Zoysa, Elise B. Morocco, Samantha B. Kaiser, Michiko Kodama, Brendan H. Grubbs, Koji Matsuo
J Gynecol Oncol. 2018;29(5):e79.  Published online 2018 June 27    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e79
         
e80 Erratum: Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube
Min Chul Choi, Jin-Sik Bae, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Ji-Ho Kim, Ki-Chan Lee, Sunghoon Lee, Je Ho Lee
J Gynecol Oncol. 2018;29(5):e80.  Published online 2018 June 20    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e80
         
e81 A practical guide to understanding, using and including patient reported outcomes in clinical trials in ovarian cancer
Michelle K. Wilson, Rebecca Mercieca-Bebber, Michael Friedlander
J Gynecol Oncol. 2018;29(5):e81.  Published online 2018 July 9    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e81
         
e84 Lynch syndrome – Muir-Torre variant: implication in gynecologic oncology
Giorgio Bogani, Umberto Leone Roberti Maggiore, Francesco Raspagliesi
J Gynecol Oncol. 2018;29(5):e84.  Published online 2018 July 23    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e84
         
e86 Treatment outcomes of high-dose-rate intracavitary brachytherapy for cervical cancer: a comparison of Ir-192 versus Co-60 sources
Thanatip Tantivatana, Kanisa Rongsriyam
J Gynecol Oncol. 2018;29(5):e86.  Published online 2018 July 23    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e86
         
Articles from Journal of Gynecologic Oncology are provided here courtesy of Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology